A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain

NCT05101317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: HMI-115
DRUG: Placebo

Sponsor

Hope Medicine (Nanjing) Co., Ltd